apceth receives manufacturer licence for somatic cell therapeutics
The research work is focused to develop stem cell and gene therapies to treat benign and malignant diseases. apceth CEO Christine Gunther said the manufacturer’s licence has been
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.